Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 8836 AL 8850

Validation of the hotspot for dorsolateral subthalamic nucleus targeting in deep brain stimulation surgery for Parkinson's disease: a post hoc analysis of a randomised controlled trial

Bolier E, Holewijn R, De Bie RMA, Beudel M, van den Munckhof P, Schuurman R, Bot M.

J Neurol Neurosurg Psychiatry. 2025 Mar 13;96(3):272-279. doi: 10.1136/jnnp-2023-333164.

Patterns, outcomes, and preventability of clinically manifest drug-drug interactions in older outpatients: a subgroup analysis from a 6-year-long observational study in North India

Kaur U, Reddy J, Reddy NTS, Gambhir IS, Yadav AK, Chakrabarti SS.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):687-698. doi: 10.1007/s00210-024-03294-2. Epub 2024 Jul 24.

Transcranial Temporal Interference Stimulation of the Right Globus Pallidus in Parkinson's Disease

Yang C, Xu Y, Feng X, Wang B, Du Y, Wang K, Lü J, Huang L, Qian Z, Wang Z, Chen N, Zhou J, Zhang C, Liu Y.

Mov Disord. 2025 Jun;40(6):1061-1069. doi: 10.1002/mds.29967. Epub 2024 Aug 12.

Genetics of Parkinson's Disease: From Causes to Treatment

Westenberger A, Brüggemann N, Klein C.

Cold Spring Harb Perspect Med. 2025 Jul 1;15(7):a041774. doi: 10.1101/cshperspect.a041774.

One side effect: two networks? Lateral and posteromedial stimulation spreads induce dysarthria in subthalamic deep brain stimulation for Parkinson's disease

Jergas H, Petry-Schmelzer JN, Hannemann JH, Thies T, Strelow JN, Rubi-Fessen I, Quinting J, Baldermann JC, Mücke D, Fink GR, Visser-Vandewalle V, Dembek TA, Barbe MT.

J Neurol Neurosurg Psychiatry. 2025 Mar 13;96(3):280-286. doi: 10.1136/jnnp-2024-333434.

Awake versus asleep deep brain stimulation for Parkinson's disease: a comprehensive systematic review and meta-analysis

Maroufi SF, Fallahi MS, Hosseinzadeh Asli S, Khorasanizadeh M, Pour-Rashidi A, Ponce FA, Slavin KV.

J Neurosurg. 2024 Aug 16;142(2):324-338. doi: 10.3171/2024.4.JNS232553. Print 2025 Feb 1.

Progress of non-motor symptoms in early-onset Parkinson's disease

Zhang F, Luo A, Liao S, Liu M, Zhang J, Xu Z.

Ibrain. 2024 Oct 9;11(4):422-438. doi: 10.1002/ibra.12180. eCollection 2025 Winter.

Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor in Fahr's Disease: Case Report

Filo J, Mustroph ML, Chua MMJ, White PJ, McDannold NJ, Cosgrove GR.

Stereotact Funct Neurosurg. 2025;103(1):63-68. doi: 10.1159/000541446. Epub 2024 Oct 21.

Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study

Oh E, Cheon SM, Cho JW, Sung YH, Kim JS, Shin HW, Kim JM, Park MY, Kwon DY, Ma H 2nd, Park JH, Koh SB, Choi SM, Park J, Lee PH, Ahn TB, Kim SJ, Lyoo CH, Lee HW, Kim J, Lee Y, Baik JS.

J Neural Transm (Vienna). 2025 Mar;132(3):431-441. doi: 10.1007/s00702-024-02851-6. Epub 2024 Nov 14.

Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial

Koszycki D, Taljaard M, Bradwejn J, Lee C, Tasca GA, Grimes DA.

Mov Disord. 2025 Aug;40(8):1539-1550. doi: 10.1002/mds.30061. Epub 2024 Nov 20.

Low-Frequency Deep Brain Stimulation in Non-Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease

Herz DM, Blech J, Winter Y, Gonzalez-Escamilla G, Groppa S.

Mov Disord. 2025 Feb;40(2):285-291. doi: 10.1002/mds.30064. Epub 2024 Nov 21.

White matter lesions contribute to motor and non-motor disorders in Parkinson's disease: a critical review

Jiang YQ, Chen QZ, Yang Y, Zang CX, Ma JW, Wang JR, Dong YR, Zhou N, Yang X, Li FF, Bao XQ, Zhang D.

Geroscience. 2025 Feb;47(1):591-609. doi: 10.1007/s11357-024-01428-1. Epub 2024 Nov 22.

The role of the immune system in Parkinson's disease pathogenesis: A focus on Th17 cells - A systematic review and meta-analysis

Jiang Z, Huang H, Chen Y, Xie H, Lu Y, Ge Y, Yao R, Wang L, Wu Z, Bu Y, Chen G, Yang D.

J Neuroimmunol. 2025 Jan 15;398:578484. doi: 10.1016/j.jneuroim.2024.578484. Epub 2024 Nov 17.

The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials

Sobral MVS, Soares VG, Moreira JLML, Rodrigues LK, Rocha P, Bendaham LCAR, Gonçalves OR, Pirolla RDC, Vilela LV, de Abreu VS, Almeida KJ.

Parkinsonism Relat Disord. 2025 Jan;130:107210. doi: 10.1016/j.parkreldis.2024.107210. Epub 2024 Nov 16.

Exposure factors and clinical characteristics associated with Parkinson's disease in GBA1 variant carriers: A Chinese GBA1-PD intrafamilial survey

Zhang X, Zhao Y, Jiang L, Hu Y, Liu Z, Xu Q, Wang C, Lei L, Li P, Tan Z, Wu H, Shen L, Jiang H, Yan X, Tang B, Guo J.

Parkinsonism Relat Disord. 2025 Jan;130:107212. doi: 10.1016/j.parkreldis.2024.107212. Epub 2024 Nov 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias